Diabetes Research and Clinical Practice
Volume 56, Issue 2 , Pages 141-145 , May 2002

Relationship of the tumor necrosis factor-α −308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus

Received 6 February 2001 ,Revised 7 August 2001 ,Accepted 25 October 2001.

References 

  1. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science. 1996;271:665–668
  2. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 1995;95:2409–2415
  3. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA. 1997;94:3195–3199
  4. Fernández-Real JM, Gutierrez C, Ricart W, et al.  The TNF-α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. Diabetes. 1997;46:1468–1472
  5. Hoffstedt J, Eriksson P, Hellström L, Rössner S, Rydén M, Arner P. Excessive fat accumulation is associated with the TNF-α −308 G/A promoter polymorphism in women but not in men. Diabetologia. 2000;43:117–120
  6. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36:54–59
  7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997) 1183–1197.
  8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  9. Katsuki A, Sumida Y, Murashima S, et al.  Serum levels of tumor necrosis factor-α are increased in obese patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1998;83:859–862
  10. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979;237:E214–223
  11. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int. J. Obes. 1983;7:437–445
  12. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem. Biophys. Res. Commun. 1995;211:833–839
  13. Hayakawa T, Nagai Y, Taniguchi M, et al.  Tumor necrosis factor-β gene Nco I polymorphism decreases insulin resistance in Japanese men. Metabolism. 2000;49:1506–1509
  14. Walston J, Seibert M, Yen CJ, Cheskin LJ, Anderson RE. Tumor necrosis factor-α −238 and −308 polymorphism do not associate with traits related to obesity and insulin resistance. Diabetes. 1999;48:2096–2098
  15. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumor necrosis factor—alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia. 1998;41:430–434
  16. Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O. The −238 and −308 G→A polymorphisms of the tumor necrosis factor α gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J. Clin. Endocrinol. Metab. 2000;85:1731–1734

PII: S0168-8227(01)00358-8

Diabetes Research and Clinical Practice
Volume 56, Issue 2 , Pages 141-145 , May 2002

Article Tools